TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for untreatable liver cancer
Disease control Not yet recruitingThis study tests a new first-line treatment for people with advanced liver cancer that cannot be removed by surgery. The treatment combines a procedure that delivers chemotherapy directly to the tumor (TACE) with two drugs that boost the immune system and block blood vessel growt…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The treatment combines low doses of two drugs (bevacizumab and atezolizumab) with a procedure that delivers chemotherapy directly to the liver. The goal is to see if this app…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC